Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Congratulations to the two Stand Up To Cancer – Cancer Research UK Paediatric Cancer New Discoveries Challenge research teams awarded renewed funding. Each team received a further $5m over three years to continue their work.
Martin McCabe (University of Manchester) and Thomas Merchant (St. Jude Children's Research Hospital) will build on initial work in the BRAINatomy study, analysing regions of the brain where radiotherapy causes damage and finding ways to mitigate this. Specifically, they'll investigate reducing doses to sensitive brain areas in patients where it's safe to do so and testing hormones.
John Anderson (University College London/Great Ormond Street Hospital), Louis Chesler (The Institute of Cancer Research) and Paul Sondel (University of Wisconsin-Madison) identified that combining CAR-T cells and immune-modulating drugs to modulate CAR-T activity and prevent T cell exhaustion was a promising approach for targeting neuroblastoma and medulloblastoma in preclinical models. They will now develop and conduct a neuroblastoma clinical trial to examine this combination treatment.
|
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
| | Congratulations to our latest population & prevention research grant awardees |
| Meet the latest grant awardees selected by our Population and Prevention Research Committee:
Luke Boulter, Cassie Clarke, Malcolm Dunlop and Lesley Stark received Biology to Prevention Awards.
Eve Roman, Eleanor Kane, Emma Vincent, Javier Gonzalez and Helena Carreira were selected for Project Awards. |
| | |
|
|
|
|
|
| | | | | We’re inviting multidisciplinary data and cancer experts to join our data challenge and use large-scale spatial biology data to further cancer research.
You’ll need to leverage the diverse experience within your group to create or develop tools for earlier cancer detection and prevention.
This free residential event, hosted in partnership with the MRC National Mouse Genetics Network will take place on 25-28 November 2024 at Mercure Glasgow City Hotel, Scotland. Domestic travel, accommodation and meal costs will be covered.
Find out more about the challenges and who we’re looking for. | | |
| | | | | | | Not long till the international brain tumour conference with three days of thought-provoking discussion, network and debate in London.
Have you got your ticket? Join the likes of Juanita Lopez (The Royal Marsden), Nada Jabado (McGill University), Arnold Kriegstein (University of California, San Francisco), Christiane Opitz (German Cancer Research Center). They’ll be sharing insights into topics including brain tumour metabolism, clinical trials, AI and spatial sequencing.
The early registration discount expires on 9 August, so register now to join the conversation. | | |
|
|---|
|
|
|
|
| | Can decentralised trials become the new normal for cancer? |
| | Known as ‘remote’, ‘digital’ or ‘virtual’ trials, decentralised clinical trials (DCTs) are gaining traction within the clinical research sector due to their potential to promote efficient, patient-centric and technologically enabled delivery of clinical trials.
Our Clinical Trial Fellow, Yemi Akala, talks us through the benefits and challenges of moving forward with DCTs by placing patients at its heart.
Read along to find out where the opportunities lie for cancer trials. |
| | |
|
|
|---|
|
|
|
|
|
| | | | | Are you looking to explore the latest approaches and development in precision medicine?
Join Mariam Jamal-Hanjani (University College London), Jaquin Mateo (Vall d’Hebron Institute of Oncology) and Lisa Derosa (Gustave Roussy) at MAP 2024 in London. You’ll have the chance to attend education sessions, young oncologist workshops, along with the ‘RoadMAP to the clinic day’ back for its second year focusing on AI in drug development. | | |
| | | | | | | If you submitted an abstract for our early detection of cancer conference, this is your opportunity to get your costs covered.
We are offering a limited number of bursaries to cover travel and accommodation costs up to £1,500 for those with an accepted poster or lightning talk.
The conference takes place in San Francisco between 22-24 October in a partnership between the Canary Center at Stanford, OHSU Knight Cancer Institute and us. | | |
|
|---|
|
|
|
|
The 2024 DSIT Research and Innovation Workforce Survey is now live |
| Your perspective is crucial in helping the Department for Science, Innovation and Technology identify trends, challenges and opportunities from the Research and Innovation (R&I) workforce. This survey will take 15-20 minutes to complete.
Your input can directly impact UK government policy and Research and Development (R&D) funding decisions. This is the second wave of this survey, with the first survey conducted in 2022 supporting R&I policy work including research talent policy, research culture and equality, diversity and inclusion.
This survey spans the full spectrum of R&I careers including but not limited to all researchers, technicians, engineers, R&I leaders, PhD students and R&D managers. |
| | |
|
|
|
What did you think of this email? |
|
| | |
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
